A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients

E. G. E. de Vries; Clarieke Venema; A. W. J. M. Glaudemans; A. Jager; F. Garner; A. O'Neill; A. Patki; Menke-van der Houven C. W. van Oordt

doi:10.1158/1538-7445.SABCS16-P2-08-08

A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients

E. G. E. de Vries, Clarieke Venema, A. W. J. M. Glaudemans, A. Jager, F. Garner, A. O'Neill, A. Patki, Menke-van der Houven C. W. van Oordt

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	2
Journal	Cancer Research
Volume	77
Issue number	4
DOIs	https://doi.org/10.1158/1538-7445.SABCS16-P2-08-08
Publication status	Published - Feb-2017
Event	San Antonio Breast Cancer Symposium - San Antonio Duration: 6-Dec-2016 → 10-Dec-2016

Access to Document

10.1158/1538-7445.SABCS16-P2-08-08

Handle.net

Persistent link

Cite this

de Vries, E. G. E., Venema, C., Glaudemans, A. W. J. M., Jager, A., Garner, F., O'Neill, A., Patki, A., & van Oordt, M. D. H. C. W. (2017). A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients. Cancer Research, 77(4). https://doi.org/10.1158/1538-7445.SABCS16-P2-08-08

@article{6c948154098c48ff95aaaf039005458f,

title = "A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients",

author = "{de Vries}, {E. G. E.} and Clarieke Venema and Glaudemans, {A. W. J. M.} and A. Jager and F. Garner and A. O'Neill and A. Patki and {van Oordt}, {Menke-van der Houven C. W.}",

year = "2017",

month = feb,

doi = "10.1158/1538-7445.SABCS16-P2-08-08",

language = "English",

volume = "77",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "AMER ASSOC CANCER RESEARCH",

number = "4",

note = "San Antonio Breast Cancer Symposium ; Conference date: 06-12-2016 Through 10-12-2016",

}

de Vries, EGE, Venema, C, Glaudemans, AWJM, Jager, A, Garner, F, O'Neill, A, Patki, A & van Oordt, MDHCW 2017, 'A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients', Cancer Research, vol. 77, no. 4. https://doi.org/10.1158/1538-7445.SABCS16-P2-08-08

A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients. / de Vries, E. G. E.; Venema, Clarieke; Glaudemans, A. W. J. M. et al.
In: Cancer Research, Vol. 77, No. 4, 02.2017.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - A phase 1 study of RAD1901, an oral selective estrogen receptor degrader, to determine changes in the F-18-FES uptake and tumor responses in ER-positive, HER2-negative, advanced breast cancer patients

AU - de Vries, E. G. E.

AU - Venema, Clarieke

AU - Glaudemans, A. W. J. M.

AU - Jager, A.

AU - Garner, F.

AU - O'Neill, A.

AU - Patki, A.

AU - van Oordt, Menke-van der Houven C. W.

PY - 2017/2

Y1 - 2017/2

U2 - 10.1158/1538-7445.SABCS16-P2-08-08

DO - 10.1158/1538-7445.SABCS16-P2-08-08

M3 - Meeting Abstract

SN - 0008-5472

VL - 77

JO - Cancer Research

JF - Cancer Research

IS - 4

T2 - San Antonio Breast Cancer Symposium

Y2 - 6 December 2016 through 10 December 2016

ER -